Annual report pursuant to Section 13 and 15(d)

Stock Options

v3.5.0.2
Stock Options
12 Months Ended
Aug. 31, 2016
Stock Options [Text Block]
12.

Stock Options

   
 

The Company has established its 2014 Stock Option Plan whereby the board of directors may, from time to time, grant up to 3,850,000 (post forward stock split) stock options to directors, officers, employees, and consultants. Stock options granted must be exercised no later than five years from the date of grant or such lesser period as determined by the Company’s board of directors. The exercise price of an option is equal to or greater than the closing market price of the Company’s common shares on the day preceding the date of grant. The vesting terms of each grant are set by the board of directors.

   
 

Fiscal 2015 Activity

   
 

On December 22, 2014, the Company granted 1,567,500 stock options to certain directors, officers and consultants, with 1,347,500 vesting immediately, 110,000 vesting in six months, and 110,000 vesting in 12 months. The options have an exercise price of $0.10 per share and expire on December 22, 2019.

   
 

On February 4, 2015, the Company granted 275,000 stock options to consultants with an exercise price of $0.09, vesting immediately, expiring February 3, 2020.

   
 

On March 26, 2015, the Company granted 550,000 stock options to an officer of the Company. The exercise price of the stock options is $0.09, vesting immediately and expiring on March 26, 2020.

   
 

Fiscal 2016 Activity

   
 

On September 16, 2015, the Company granted 110,000 stock options to a director of the Company. The exercise price of the stock options is $0.17, vesting immediately and expiring on September 16, 2020.

   
 

On April 15, 2016, the Company granted 300,000 to an officer of the Company. The exercise price of the stock options is $0.11 per share, vesting immediately and expiring on April 15, 2021.

   
 

On June 3, 2016, the Company granted 325,000 stock options to a consultant, vesting immediately, with an exercise price of $0.14 and expiring five years from the date of grant.

During the year ended August 31, 2016, the Company recorded a total $122,015 (2015– $256,051) as stock based compensation expense of which $83,865 (2015 - $200,734) pertained to the stock options granted during the year with the remaining being the recognition of expense from previous grants.

A continuity schedule for stock options is presented below:

            Weighted Average  
      Number of     Exercise Price  
      Options     $  
  Balance, August 31, 2014 (vested and outstanding)   2,887,500     0.22  
  Expired   (1,210,000 )   0.21  
  Granted   2,392,500     0.10  
  Balance, August 31, 2015 (vested and outstanding)   4,070,000     0.15  
  Expired   (385,000 )   0.32  
  Cancelled   (935,000 )   0.16  
  Granted   735,000     0.13  
  Balance, August 31, 2016 (vested and outstanding)   3,485,000     0.13  

The fair value of options granted was estimated as of the date of the grant by using the Black-Scholes option pricing model with the following assumptions:

  August 31 August 31
  2016 2015
Expected volatility 240% - 241% 243% - 249%
Risk-free interest rate 1.22% - 1.62% 1.47% - 1.66%
Expected life 5.00 years 5.00 years
Dividend yield 0.00% 0.00%
Estimated fair value per option $0.11 - $0.19 $0.08 - $0.10

A summary of the Company’s vested and outstanding stock options as at August 31, 2016 is presented below:

# of Stock Weighted   Weighted     Aggregate  
Options Average   Average     Intrinsic Value  
  Remaining   Exercise Price        
  Contractual Life   $     $  
247,500 1.80 years   0.09     4,950  
660,000 2.90 years   0.23     (85,800 )
1,017,500 3.31 years   0.10     10,175  
275,000 3.43 years   0.09     5,500  
550,000 3.57 years   0.09     11,000  
110,000 4.05 years   0.17     (7,700 )
300,000 4.62 years   0.11     3,000  
325,000 4.76 years   0.14     (6,500 )
3,485,000 3.45 years   0.13     (65,375 )